I have not read the whole article, but this abstract is...

I have not read the whole article, but this abstract is featured:

Wearable company shares plenty with pharma in development and commercialization challenges
By Guy Martin
02-07-2018
Pharma companies sometimes need to be aware of advances in wearable technology that threaten to take market share away from their medicines, but such devices can also work well when used in conjunction with drugs. The latter looks likely to be true of an innovative technology called Mente Autism (pictured above, with patient), developed by Malta-based AAT Medical, a wholly-owned subsidiary of Neurotech International (ASX:NTI).

https://www.thepharmaletter.com/art...-development-and-commercialization-challenges

(Needs subscriptions)